Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Cough D003371 19 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Ataxia D001259 20 associated lipids
Brain Edema D001929 20 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Breast Neoplasms D001943 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hyperemia D006940 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Endotoxemia D019446 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Neuralgia D009437 28 associated lipids
Obesity D009765 29 associated lipids
Catalepsy D002375 30 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Memory Disorders D008569 33 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Fever D005334 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Epilepsy D004827 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Hypotension D007022 41 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Fatty Liver D005234 48 associated lipids
Nerve Degeneration D009410 53 associated lipids
Pain D010146 64 associated lipids
Reperfusion Injury D015427 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Stomach Ulcer D013276 75 associated lipids
Alzheimer Disease D000544 76 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Seizures D012640 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Hillard CJ et al. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. 1995 J. Neurochem. pmid:7830060
Wartmann M et al. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. 1995 FEBS Lett. pmid:7867785
Bornheim LM et al. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. 1995 Biochem. Pharmacol. pmid:7669071
Desarnaud F et al. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. 1995 J. Biol. Chem. pmid:7890734
Fride E et al. Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. 1995 J. Pharmacol. Exp. Ther. pmid:7853184
Di Marzo V and Fontana A Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7675818
Romero J et al. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. 1995 Pharmacol. Biochem. Behav. pmid:7675852
Das SK et al. Cannabinoid ligand-receptor signaling in the mouse uterus. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7753807
Fan P Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. 1995 J. Neurophysiol. pmid:7760148
Ueda N et al. Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732825
Facci L et al. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7724569
Fride E Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol. 1995 Brain Res. pmid:8593598
Ueda N and Yamamoto S [Anandamide: a marijuana-like compound produced in animal tissues]. 1995 Tanpakushitsu Kakusan Koso pmid:8532892
Maurelli S et al. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. 1995 FEBS Lett. pmid:8543025
Pate DW et al. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. 1995 Curr. Eye Res. pmid:8529418
Lee M et al. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. 1995 J. Pharmacol. Exp. Ther. pmid:7473135
Schmid PC et al. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. 1995 FEBS Lett. pmid:7498458
Sugiura T et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. 1995 Biochem. Biophys. Res. Commun. pmid:7575630
Guzmán M et al. Effects of anandamide on hepatic fatty acid metabolism. 1995 Biochem. Pharmacol. pmid:7575652
Ueda N et al. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. 1995 J. Biol. Chem. pmid:7559559
Venance L et al. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. 1995 Nature pmid:7637807
Ueda N [Anandamide: an endogenous cannabinoid receptor agonist]. 1995 Seikagaku pmid:7594870
Varga K et al. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. 1995 Eur. J. Pharmacol. pmid:7589169
Mechoulam R et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. 1995 Biochem. Pharmacol. pmid:7605349
Felder CC et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. 1995 Mol. Pharmacol. pmid:7565624
Vela G et al. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. 1995 Neuropharmacology pmid:7566503
Paria BC et al. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7568154
Burstein SH and Hunter SA Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC). 1995 Biochem. Pharmacol. pmid:7702643
Collin C et al. Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7479747
Pertwee RG et al. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. 1995 Eur. J. Pharmacol. pmid:7713152
Romero J et al. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. 1995 Brain Res. pmid:8974649
Ueda N et al. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. 1995 Biochim. Biophys. Acta pmid:7827116
Edgemond WS et al. The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors. 1995 Feb-Mar Prostaglandins Leukot. Essent. Fatty Acids pmid:7784462
Koga D et al. High-performance liquid chromatography and fluorometric detection of arachidonylethanolamide (anandamide) and its analogues, derivatized with 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulp honyl-2,1 ,3- benzoxadiazole (DBD-COCl). 1995 Jan-Feb Biomed. Chromatogr. pmid:7734936
Shimasue K et al. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. 1996 Eur. J. Pharmacol. pmid:8904088
Sugiura T et al. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. 1996 Biochem. Biophys. Res. Commun. pmid:8573114
Jarho P et al. Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide. 1996 Life Sci. pmid:8602110
Skaper SD et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8633002
Wise ML et al. Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. 1996 Experientia pmid:8575565
Pan X et al. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. 1996 Mol. Pharmacol. pmid:8609900
Fride E and Mechoulam R Developmental aspects of anandamide: ontogeny of response and prenatal exposure. 1996 Psychoneuroendocrinology pmid:8774060
Showalter VM et al. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. 1996 J. Pharmacol. Exp. Ther. pmid:8819477
Felder CC et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. 1996 FEBS Lett. pmid:8814296
di Tomaso E et al. Brain cannabinoids in chocolate. 1996 Nature pmid:8751435
Cadas H et al. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. 1996 J. Neurosci. pmid:8656287
Kempe K et al. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. 1996 J. Biol. Chem. pmid:8663381
Shivachar AC et al. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. 1996 Biochem. Pharmacol. pmid:8615904
Cravatt BF et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. 1996 Nature pmid:8900284
James JS Marijuana and chocolate. 1996 AIDS Treat News pmid:11363932
Thomas BF et al. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. 1996 J. Med. Chem. pmid:8558515